Search results - 12 results
COVID-19 vaccine responses are influenced by distinct risk factors in naive and SARS-CoV-2 experienced hemodialysis recipients
Olislagers; Daphnée Georges; Emilie Dhondt; Margarida Braga; Heyndrickx, Leo; Johan Michiels; Anaïs Thiriard; Anne Lemy; Thomas Baudoux; Marylène Vandevenne; Maria Goossens; André Matagne; Isabelle Desombere; ...
Hybrid Immunity Overcomes Defective Immune Response to COVID-19 Vaccination in Kidney Transplant Recipients
Olislagers; Daphnée Georges; Emilie Dhondt; Margarida Braga; Leo Heyndrickx; Johan Michiels; Anaïs Thiriard; Anne Lemy; Marylène Vandevenne; Maria Goossens; André Matagne; I sabelle Desombere; Kevin K. Ariën; ...
Humoral and cellular immune correlates of protection against COVID-19 in kidney transplant recipients.
Lemy, Anne; Maria Goossens; I Desombere; Michiels, Johan; Vandevenne, Marylène; Heyndrickx, Leo; Ariën, Kevin K; Matagne, André; Ackerman, Margaret E; Le Moine, Alain; Marchant, Arnaud Source: Am ...
Third dose of COVID-19 mRNA vaccine closes the gap in immune response between naïve nursing home residents and healthy adults.
Craeye; Antoine Francotte; Félicie Chaumont; Celien Van Oostveldt; Heyndrickx, Leo; Johan Michiels; Willems, Elisabeth; Emilie Dhondt; Marharyta Krauchuk; Marie-Noëlle Schmickler; Mathieu Verbrugghe; Nele ...
Safety and immunogenicity of a reduced dose of the BNT162b2 mRNA COVID-19 vaccine (REDU-VAC): A single blind, randomized, non-inferiority trial
Publication Type: Peer reviewed scientific article Authors: Pieter Pannus; Stéphanie Depickère; Delphine Kemlin; Sarah Houben; Kristof Y. Neven; Heyndrickx, Leo; Johan Michiels; Willems, Elisabeth; ...
Safety and immunogenicity of a reduced dose of the BNT162b2 mRNA COVID-19 vaccine (REDU-VAC): A single blind, randomized, non-inferiority trial (poster)
Publication Type: Scientific poster, presentation or proceeding Authors: Pieter Pannus; Stéphanie Depickère; Delphine Kemlin; Sarah Houben; Christophe Y. Neven; Leo Hendrickx; Johan Michiels ...
Antibody response against SARS-CoV-2 Delta and Omicron variants after third-dose BNT162b2 vaccination in allo-HCT recipients.
Evelyne Willems; Grégory Ehx; Stanislas Goriely; Laurence Seidel; Johan Michiels; Betty Willems; Maria Goossens; Yves Beguin; Arnaud Marchant; Frédéric Baron Source: Cancer Cell, Volume 40, Issue 4 (2022) ...
Three doses of BNT162b2 vaccine confer neutralising antibody capacity against the SARS-CoV-2 Omicron variant.
Publication Type: Peer reviewed scientific article Authors: Ariën, Kevin K; Heyndrickx, Leo; Johan Michiels; Katleen Vereecken; Kurt Van Lent; Sandra Coppens; Betty Willems; Pieter Pannus; Geert ...
Poor antibody response to BioNTech/Pfizer COVID-19 vaccination in SARS-CoV-2 naïve residents of nursing homes.
Publication Type: Peer reviewed scientific article Authors: Pieter Pannus; Kristof Y Neven; Stéphane De Craeye; Heyndrickx, Leo; Sara Vande Kerckhove; Daphnée Georges; Johan Michiels; Antoine ...
Predictors of neutralizing antibody response to BNT162b2 vaccination in allogeneic hematopoietic stem cell transplant recipients.
Evelyne Willems; Grégory Ehx; Stanislas Goriely; Laurence Seidel; Johan Michiels; Betty Willems; Adrian Liston; Ariën, Kevin K; Yves Beguin; Maria Goossens; Arnaud Marchant; Frédéric Baron Source: J Hematol ...